Jiang Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jiang Wu has a total of 132 co-authors. Here are the top co-authors by number of shared publications:
- Huacheng He
Department of Endocrinology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China
22 shared publications Anqi Chen
Department of Dermatology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China
8 shared publications- Jie Zheng
The University of Texas at San Antonio
8 shared publications Ying An
Wenzhou Med Univ, Sch Pharmaceut Sci, Key Lab Biotechnol & Pharmaceut Engn, Wenzhou 325035, Zhejiang, Peoples R China
8 shared publicationsJie Xu
School of Pharmaceutical Sciences Key Laboratory of Biotechnology and Pharmaceutical Engineering Wenzhou Medical University Wenzhou Zhejiang China
7 shared publicationsWen Huang
School of Pharmaceutical Science Wenzhou Medical University Wenzhou Zhejiang 325035 P. R. China
6 shared publications
Latest Publications
- Open Access
- 2 September 2026
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (9) , 1389
Electrospun Heparin-Loaded PCL Nanofiber Sutures with Sustained Release for Antithrombotic Applications
Background/Objectives: Conventional surgical sutures can promote local coagulation after implantation, potentially compromising vascular patency. Heparin is an effective anticoagulant, but systemic administration may cause bleeding and thrombocytopenia. This study aimed to develop an electrospun heparin-loaded polycaprolactone (PCL) suture that combines structural support with sustained local heparin delivery and antithrombotic activity. Methods: Heparin was incorporated into electrospun PCL sutures at nominal heparin-to-PCL feed ratios of 0.05 and 0.50 wt%. Fiber morphology, chemical characteristics, tensile properties, heparin release, molecular interactions, cytocompatibility, hemolysis, and plasma recalcification were evaluated. Molecular dynamics simulations were used to investigate PCL–heparin interactions. In vivo antithrombotic performance was assessed in a liver puncture model using male C57BL/6 mice, followed by histological examination. Results: Heparin incorporation preserved the fibrous morphology of the sutures, although maximum tensile stress and strain were modestly reduced compared with PCL alone. Both heparin-loaded formulations exhibited sustained heparin release over 10 days, and molecular dynamics simulations indicated stable PCL–heparin interactions. Cell viability did not differ significantly among the suture groups, and all hemolysis rates remained below 5%. In the plasma recalcification assay, both heparin-loaded groups remained incompletely coagulated at 300 s, indicating marked anticoagulant activity. In the mouse liver injury model, heparin-loaded sutures reduced local clot formation compared with PCL sutures. Conclusions: Electrospun heparin-loaded PCL sutures integrate sustained local heparin delivery with in vitro anticoagulant and in vivo antithrombotic activity. These findings support further evaluation of this multifunctional suture platform in clinically relevant vascular models.
- 2 September 2026
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (9) , 1389
Open AccessElectrospun Heparin-Loaded PCL Nanofiber Sutures with Sustained Release for Antithrombotic Applications
Background/Objectives: Conventional surgical sutures can promote local coagulation after implantation, potentially compromising vascular patency. Heparin is an effective anticoagulant, but systemic administration may cause bleeding and thrombocytopenia. This study aimed to develop an electrospun heparin-loaded polycaprolactone (PCL) suture that combines structural support with sustained local heparin delivery and antithrombotic activity. Methods: Heparin was incorporated into electrospun PCL sutures at nominal heparin-to-PCL feed ratios of 0.05 and 0.50 wt%. Fiber morphology, chemical characteristics, tensile properties, heparin release, molecular interactions, cytocompatibility, hemolysis, and plasma recalcification were evaluated. Molecular dynamics simulations were used to investigate PCL–heparin interactions. In vivo antithrombotic performance was assessed in a liver puncture model using male C57BL/6 mice, followed by histological examination. Results: Heparin incorporation preserved the fibrous morphology of the sutures, although maximum tensile stress and strain were modestly reduced compared with PCL alone. Both heparin-loaded formulations exhibited sustained heparin release over 10 days, and molecular dynamics simulations indicated stable PCL–heparin interactions. Cell viability did not differ significantly among the suture groups, and all hemolysis rates remained below 5%. In the plasma recalcification assay, both heparin-loaded groups remained incompletely coagulated at 300 s, indicating marked anticoagulant activity. In the mouse liver injury model, heparin-loaded sutures reduced local clot formation compared with PCL sutures. Conclusions: Electrospun heparin-loaded PCL sutures integrate sustained local heparin delivery with in vitro anticoagulant and in vivo antithrombotic activity. These findings support further evaluation of this multifunctional suture platform in clinically relevant vascular models.
- 21 June 2026
- Published by Wiley in Advanced Functional Materials
- Vol. 36 (56)
Translating Traditional Chinese Medicine Into Advanced Hemostatic and Wound Healing Sponges
Uncontrolled hemorrhage complicated by bacterial infection remains a critical challenge in trauma management. Developing multifunctional materials that integrate rapid hemostasis with antibacterial protection is essential for improving clinical outcomes. In this study, polysaccharides from four Traditional Chinese Medicines (TCMs)— Polygonatum Sibiricum , Astragalus Membranaceus , Bletilla Striata , and Dendrobium Officinale —were selected via network pharmacology and fabricated into hemostatic sponges using a one‐pot periodate oxidation method. The resulting sponges exhibited robust hemostatic efficacy, significantly outperforming commercial Gelatin in lethal femoral artery, liver injury, and tail amputation models. Mechanistic analysis revealed that this performance arises from a synergistic interplay of capillary‐driven blood concentration, aldehyde‐mediated tissue adhesion, and intrinsic bioactivity that triggers platelet activation and accelerates fibrin network formation. Notably, structure‐function profiling identified distinct performance advantages: the Astragalus Membranaceus ‐derived sponge (APS) demonstrated the fastest absorption kinetics and strongest platelet activation for acute hemostasis, while the Bletilla Striata ‐derived sponge (BPS) and Dendrobium Officinale ‐ derived sponge (DPS) provided an optimal balance of clotting efficiency and regenerative potential. In infected full‐thickness skin defects, the sponges significantly accelerated healing by eliminating bacteria and promoting granulation tissue formation, angiogenesis, and collagen maturation. This work demonstrates that rationally engineered TCM polysaccharides can serve as advanced, bioactive scaffolds for the simultaneous management of hemorrhage and wound infection.
- 21 June 2026
- Published by Wiley in Advanced Functional Materials
- Vol. 36 (56)
Translating Traditional Chinese Medicine Into Advanced Hemostatic and Wound Healing Sponges
Uncontrolled hemorrhage complicated by bacterial infection remains a critical challenge in trauma management. Developing multifunctional materials that integrate rapid hemostasis with antibacterial protection is essential for improving clinical outcomes. In this study, polysaccharides from four Traditional Chinese Medicines (TCMs)— Polygonatum Sibiricum , Astragalus Membranaceus , Bletilla Striata , and Dendrobium Officinale —were selected via network pharmacology and fabricated into hemostatic sponges using a one‐pot periodate oxidation method. The resulting sponges exhibited robust hemostatic efficacy, significantly outperforming commercial Gelatin in lethal femoral artery, liver injury, and tail amputation models. Mechanistic analysis revealed that this performance arises from a synergistic interplay of capillary‐driven blood concentration, aldehyde‐mediated tissue adhesion, and intrinsic bioactivity that triggers platelet activation and accelerates fibrin network formation. Notably, structure‐function profiling identified distinct performance advantages: the Astragalus Membranaceus ‐derived sponge (APS) demonstrated the fastest absorption kinetics and strongest platelet activation for acute hemostasis, while the Bletilla Striata ‐derived sponge (BPS) and Dendrobium Officinale ‐ derived sponge (DPS) provided an optimal balance of clotting efficiency and regenerative potential. In infected full‐thickness skin defects, the sponges significantly accelerated healing by eliminating bacteria and promoting granulation tissue formation, angiogenesis, and collagen maturation. This work demonstrates that rationally engineered TCM polysaccharides can serve as advanced, bioactive scaffolds for the simultaneous management of hemorrhage and wound infection.
- 17 June 2026
- Published by Portland Press Ltd. in Clinical Science
- Vol. 140 (7) , 1317-1340
FGF2 in the regulation of regenerative repair and fibrosis: TGF-β cross-talk and therapeutic advances
Regenerative repair following tissue injury depends on tightly coordinated signaling networks that determine whether healing culminates in functional restoration or fibrotic scarring. Among these regulators, fibroblast growth factor-2 (FGF2) has emerged as a key modulator of repair outcomes. Mechanistically, FGF2 promotes inflammation resolution, proliferation, vascularization, and re-epithelialization. A central feature of its activity is dynamic cross-talk with transforming growth factor-β (TGF-β), a dominant driver of extracellular matrix deposition and fibrosis. Accumulating evidence indicates that FGF2 inhibits TGF-β-mediated profibrotic signaling, thereby shifting tissue remodeling toward regeneration rather than pathological outcomes. This interaction is supported by both preclinical and clinical evidence showing that FGF2 accelerates wound closure and improves scar architecture. However, despite the compelling biological rationale, the widespread clinical translation of FGF2 has been limited by rapid protein degradation and concerns about proliferative signaling in oncogenic contexts. These limitations have constrained its incorporation into standard therapeutic strategies for chronic wounds and fibrotic disorders. This review provides a synthesis of current mechanistic insights into FGF2 signaling and elucidates its regulatory interplay with TGF-β that favors regenerative repair over fibrosis. We evaluated clinical trial evidence and examined next-generation strategies to overcome translational barriers, including molecular engineering, chimeric growth factor design, and advanced stabilization approaches. By clarifying the regulatory role of FGF2 in the repair trajectory, we highlight its potential to recalibrate fibrotic responses and improve regenerative outcomes.
- 17 June 2026
- Published by Portland Press Ltd. in Clinical Science
- Vol. 140 (7) , 1317-1340
FGF2 in the regulation of regenerative repair and fibrosis: TGF-β cross-talk and therapeutic advances
Regenerative repair following tissue injury depends on tightly coordinated signaling networks that determine whether healing culminates in functional restoration or fibrotic scarring. Among these regulators, fibroblast growth factor-2 (FGF2) has emerged as a key modulator of repair outcomes. Mechanistically, FGF2 promotes inflammation resolution, proliferation, vascularization, and re-epithelialization. A central feature of its activity is dynamic cross-talk with transforming growth factor-β (TGF-β), a dominant driver of extracellular matrix deposition and fibrosis. Accumulating evidence indicates that FGF2 inhibits TGF-β-mediated profibrotic signaling, thereby shifting tissue remodeling toward regeneration rather than pathological outcomes. This interaction is supported by both preclinical and clinical evidence showing that FGF2 accelerates wound closure and improves scar architecture. However, despite the compelling biological rationale, the widespread clinical translation of FGF2 has been limited by rapid protein degradation and concerns about proliferative signaling in oncogenic contexts. These limitations have constrained its incorporation into standard therapeutic strategies for chronic wounds and fibrotic disorders. This review provides a synthesis of current mechanistic insights into FGF2 signaling and elucidates its regulatory interplay with TGF-β that favors regenerative repair over fibrosis. We evaluated clinical trial evidence and examined next-generation strategies to overcome translational barriers, including molecular engineering, chimeric growth factor design, and advanced stabilization approaches. By clarifying the regulatory role of FGF2 in the repair trajectory, we highlight its potential to recalibrate fibrotic responses and improve regenerative outcomes.
- Open Access
- 1 May 2026
- Published by KEAI Publishing in Bioactive Materials
- Vol. 59, 463-491
Antifreezing hydrogels for biomedical applications from design strategies to emerging multifunctionality
Antifreezing hydrogels are gaining increasing attention as promising materials for biomedical applications in subzero environments, including cryopreservation, cold-adaptive bioelectronics, wearable sensing, and tissue engineering. Despite recent progress, this is still a relatively underexplored research area, with many fundamental and translational challenges remaining. However, the unique ability of antifreezing hydrogels to sustain flexibility, conductivity, and biological compatibility under freezing conditions underscores their immense potential for future biomedical and engineering innovations. This review provides a targeted overview of the design principles, antifreezing mechanisms, and application-specific adaptations of antifreezing hydrogels. We begin by summarizing fundamental antifreezing strategies, including the incorporation of cryoprotective agents, polymer network engineering, crosslinking architectures, and supramolecular self-healing designs. Particular emphasis is placed on recent advances in hydrogels with integrated strain-sensing, temperature-responsiveness, and multifunctional biosensing capabilities under extreme cold conditions. We then examine cryopreservation-oriented hydrogels, highlighting their ability to suppress ice nucleation, minimize intracellular ice formation, and preserve biological function. The review also explores hydrogel-based cold-adaptive bioelectronics, including low-temperature wearable sensors, flexible circuits, and self-powered interfaces. Finally, we discuss key considerations for clinical translation, such as biocompatibility, degradability, and long-term stability. By linking molecular design to macroscopic performance, this review aims to establish a forward-looking framework for antifreezing hydrogel development across biomedical, environmental, and soft robotic domains.
- 1 May 2026
- Published by KEAI Publishing in Bioactive Materials
- Vol. 59, 463-491
Open AccessAntifreezing hydrogels for biomedical applications from design strategies to emerging multifunctionality
Antifreezing hydrogels are gaining increasing attention as promising materials for biomedical applications in subzero environments, including cryopreservation, cold-adaptive bioelectronics, wearable sensing, and tissue engineering. Despite recent progress, this is still a relatively underexplored research area, with many fundamental and translational challenges remaining. However, the unique ability of antifreezing hydrogels to sustain flexibility, conductivity, and biological compatibility under freezing conditions underscores their immense potential for future biomedical and engineering innovations. This review provides a targeted overview of the design principles, antifreezing mechanisms, and application-specific adaptations of antifreezing hydrogels. We begin by summarizing fundamental antifreezing strategies, including the incorporation of cryoprotective agents, polymer network engineering, crosslinking architectures, and supramolecular self-healing designs. Particular emphasis is placed on recent advances in hydrogels with integrated strain-sensing, temperature-responsiveness, and multifunctional biosensing capabilities under extreme cold conditions. We then examine cryopreservation-oriented hydrogels, highlighting their ability to suppress ice nucleation, minimize intracellular ice formation, and preserve biological function. The review also explores hydrogel-based cold-adaptive bioelectronics, including low-temperature wearable sensors, flexible circuits, and self-powered interfaces. Finally, we discuss key considerations for clinical translation, such as biocompatibility, degradability, and long-term stability. By linking molecular design to macroscopic performance, this review aims to establish a forward-looking framework for antifreezing hydrogel development across biomedical, environmental, and soft robotic domains.
- Open Access
- 19 February 2026
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 17, 1781606
Dynamic remodeling of skin microbiota during healthy homeostatic and wound repair conditions
The skin microbiota is a fundamental component of the cutaneous ecosystem and plays an important role in maintaining skin homeostasis through immune education, maintenance of the skin barrier, colonization resistance, and regulation of the physiological environment under healthy conditions. Skin injury disrupts this balanced microbial ecosystem, resulting in marked changes in the local microenvironment. However, the processes by which skin microbiota reorganise following injury and contribute to the restoration of a remodelled homeostatic ecosystem after wound repair are not fully understood. This review synthesizes current knowledge on host–microbiota interactions across the dynamic transition from healthy skin to wounded skin and to remodeled homeostatic skin. We highlight the functions of commensal microorganisms during the inflammatory, proliferative, and remodeling phases of wound healing, with a particular focus on their roles in the resolution of inflammation, tissue regeneration and barrier restoration. Finally, we discuss emerging microbiota-based therapeutic opportunities for wound management and outline key challenges and future research directions aimed at promoting long-term restoration of skin microbial homeostasis.
- 19 February 2026
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 17, 1781606
Open AccessDynamic remodeling of skin microbiota during healthy homeostatic and wound repair conditions
The skin microbiota is a fundamental component of the cutaneous ecosystem and plays an important role in maintaining skin homeostasis through immune education, maintenance of the skin barrier, colonization resistance, and regulation of the physiological environment under healthy conditions. Skin injury disrupts this balanced microbial ecosystem, resulting in marked changes in the local microenvironment. However, the processes by which skin microbiota reorganise following injury and contribute to the restoration of a remodelled homeostatic ecosystem after wound repair are not fully understood. This review synthesizes current knowledge on host–microbiota interactions across the dynamic transition from healthy skin to wounded skin and to remodeled homeostatic skin. We highlight the functions of commensal microorganisms during the inflammatory, proliferative, and remodeling phases of wound healing, with a particular focus on their roles in the resolution of inflammation, tissue regeneration and barrier restoration. Finally, we discuss emerging microbiota-based therapeutic opportunities for wound management and outline key challenges and future research directions aimed at promoting long-term restoration of skin microbial homeostasis.
- Top Cited PapersOpen Access
- 21 May 2025
- Published by Royal Society of Chemistry (RSC) in Chemical Society Reviews
- Vol. 54 (11) , 5292-5341
Antifreezing hydrogels: from mechanisms and strategies to applications
Antifreezing hydrogels, as an innovative solution for maintaining functional performance and mechanical integrity in subzero environments, offer a robust alternative to traditional water-free materials that often fail in wet, cold conditions.
- 21 May 2025
- Published by Royal Society of Chemistry (RSC) in Chemical Society Reviews
- Vol. 54 (11) , 5292-5341
Top Cited PapersOpen AccessAntifreezing hydrogels: from mechanisms and strategies to applications
Antifreezing hydrogels, as an innovative solution for maintaining functional performance and mechanical integrity in subzero environments, offer a robust alternative to traditional water-free materials that often fail in wet, cold conditions.
- 27 March 2025
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 308, 142500
General fabrication of bioactive dissolving microneedles from whole grain seeds derived starch for transdermal application
- 27 March 2025
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 308, 142500
General fabrication of bioactive dissolving microneedles from whole grain seeds derived starch for transdermal application
- 31 October 2024
- Published by Elsevier in Journal of Controlled Release
- Vol. 376, 701-716
Drug conjugates crosslinked bioresponsive hydrogel for combination therapy of diabetic wound
- 31 October 2024
- Published by Elsevier in Journal of Controlled Release
- Vol. 376, 701-716
Drug conjugates crosslinked bioresponsive hydrogel for combination therapy of diabetic wound
- 18 October 2024
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 282 (Pt 1) , 136486
Bio-inspired aFGF modification functionalized piezoelectric chitosan films for promoting scald wound healing
- 18 October 2024
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 282 (Pt 1) , 136486
Bio-inspired aFGF modification functionalized piezoelectric chitosan films for promoting scald wound healing